Do fraudsters deserve a second chance?

In January, we were accused of bullying. We were writing about a researcher who had 16 papers retracted for fake peer reviews; when we found out he was trying to find a new job in academia, we posted a follow-up that linked to his CV. Some commenters called the post “bullying,” “unethical,” and “over the … Continue reading Do fraudsters deserve a second chance?

Heart journal issues expression of concern after fraud report

The American Heart Association’s journal Circulation has issued an expression of concern for a paper about the molecular underpinnings of arrhythmias that was co-authored by a biomedical engineer who committed fraud on a massive scale. According to an investigation by the Office of Research Integrity (ORI), former Vanderbilt engineer Igor Dzhura faked nearly 70 images and drastically over-estimated … Continue reading Heart journal issues expression of concern after fraud report

Several chem journals neutralize papers from Brazil group over figure fraud

Several journals have retracted or corrected papers from a group at State University of Maringá in Brazil over what one chemistry journal calls “fraudulent use” of figures previously published by the authors. Química Nova, which is retracting a 2013 paper, issued a notice that taps an additional eight articles with Angelica Lazarin as the corresponding author … Continue reading Several chem journals neutralize papers from Brazil group over figure fraud

“FDA has repeatedly hidden evidence of scientific fraud,” says author of new study

For decades, the U.S. FDA has uncovered misconduct in clinical trials but hidden it from the public, according to a new paper in JAMA Internal Medicine. The study, by New York University journalism professor Charles Seife, looked at 78 publications resulting from trials where the FDA found serious misconduct, including “failure to protect the safety of patients” and … Continue reading “FDA has repeatedly hidden evidence of scientific fraud,” says author of new study

Fraud’s long tail: Measles outbreak shows why it’s important to look downstream of retractions

As Retraction Watch readers know, public health officials are concerned about a U.S. measles outbreak. As The New York Times notes: The United States has already had more cases of measles in the first month of 2015 than the number that is typically diagnosed in a full year. This follows a year in which the number of … Continue reading Fraud’s long tail: Measles outbreak shows why it’s important to look downstream of retractions

After 25 years, AIDS fraud comes back swinging

Henk Buck, a Dutch chemist who once claimed he could cure AIDS, is back, publishing a long explanation of why he was right all along in a journal by what Jeffrey Beall calls a possible predatory publisher. Buck spent a few months in 1990 as a hero. In April of that year, he and his team published … Continue reading After 25 years, AIDS fraud comes back swinging

Fraud retraction appears for deceased Maryland dental researcher

A former dental researcher at the University of Maryland, Baltimore, has lost a 2009 paper in the journal Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology for fabricating his data on an NIH-funded study. The researcher, Mark A. Scheper, is not identified in the retraction notice as the person implicated in the university … Continue reading Fraud retraction appears for deceased Maryland dental researcher